## Abstract LโAsparaginaseโinduced coagulation abnormalities were observed in all patients receiving this drug. All patients studied demonstrated low factor IX and fibrinogen levels and most (75%) had low levels of factor XI. Disturbances in other factors were much less frequent. Despite the presen
Intracranial bleeding during therapy with L-asparaginase in childhood acute lymphocytic leukemia
โ Scribed by Ch. Urban; W. -D. Sager
- Book ID
- 104776374
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 674 KB
- Volume
- 137
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
โฆ Synopsis
Two patients developed clinical features of intracranial bleeding--which were confirmed by computerized axial tomograms--during their induction therapy for acute lymphocytic leukemia. Coagulation studies showed clotting abnormalities including severe hypofibrinogenemia. These findings most probably were related to the effect of L-asparaginase which was part of the treatment protocol. Central nervous system leukemia, intrathecal chemotherapy, cranial irradiation, extreme leukocytosis, or thrombopenia at the time of diagnosis or day of stroke did not appear to be predisposing factors in these cases.
๐ SIMILAR VOLUMES
A remission-induction regimen for childhood leukemia using cyclophosphamide, asparaginase, vincristine, and prednisone (CAVP) was compared to standard vincristine-prednisone (VP) induction. The more intensive regimen was associated with a lower complete remission rate (81% vs 93%) and a higher early
## Abstract Four patients with acute lymphocytic leukemia previously treated with conventional chemotherapy received intramuscular Lโasparaginase in combination with other chemotherapy for reinduction and maintenance therapy. These patients received the Lโasparaginase for 8, 14, 27, and 34+ months
## Abstract Eleven patients with acute lymphocytic leukemia in relapse were treated with Lโasparaginase and cytosine arabinoside (1โฮฒโDโarabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 1